Mubarik Sumaira, Cao Jinhong, Wang Fang, Hussain Syeda Rija, Liu Qing, Wang Suqing, Liu Yan, Yu Chuanhua
Department of Epidemiology and Biostatistics, School of Public Health, Wuhan University, Wuhan, China.
Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, China.
Front Nutr. 2022 Apr 11;9:817836. doi: 10.3389/fnut.2022.817836. eCollection 2022.
Due to its higher prevalence and heterogeneity, female breast cancer (BC) is the widest disease throughout the world. We sought to assess the epidemiological and sociodemographic transitions of BC and to identify the potential risk factors attributed to burden of BC in East Asia.
At the regional level of East Asia and at a national level of East Asian countries, we investigated the burden of the incidence of female BC, mortality, and disability-adjusted life years (DALYs) in 2019 and assessed the epidemiological, socioeconomic, and health-linked disparities in incidence of BC and mortality over a 30-year period. The changes in BC's mortality and DALYs between 1990 and 2019, attributable to varying risk factors, were evaluated in different age groups.
In 2019, the incidence of and mortality from and DALYs of BC were estimated to be 382,321 (95% UI: 303,308-477,173) incidence cases [age-standardized rate (ASR) of 35.69 per 100,000; 28.32-44.54], 98,162 (79,216-120,112) deaths (ASR of 9.12; 7.36-11.13), and 3,024,987 (2,477, 984-3,659,370) DALYs with an ASR of 282.15 (230.81-341.19) in 2019. It was also observed that out of four most representative locations of East Asia, two (China and Japan) showed more than 60% increase in age-standardized incidence rate between 1990 and 2019. While only Japan females showed a significant rise of 15.3% (95% UI: 2.3-28) in ASR of death and 12.6% (95% UI: 0.5-26.9) in ASR of DALYs between 1990 and 2019. Inclusively, 88 and 81% variations were explained in the incidence of BC and death due to change in sociodemographic index (SDI) in 2019, in East Asia. The highest positive percent changes in death and DALYs between 1990 and 2019 were attributable to high body mass index (BMI), high fasting plasma glucose (FPG), and alcohol consumption in East Asia.
The burden of death and disability from female BC is the result of multiple risk factors, mainly due to behavioral and metabolic risk factors. The increase of the incidence is related to the westernized lifestyle and diet habits and the improvement of screening and diagnosis techniques in the recent years, whereas the increase in DALYs is mainly attributed to high BMI, high FPG, alcohol use, and high diet in red meat.
由于女性乳腺癌(BC)的患病率较高且具有异质性,它是全球范围内最为广泛的疾病。我们试图评估BC的流行病学和社会人口学转变,并确定东亚地区BC负担的潜在风险因素。
在东亚区域层面以及东亚国家的国家层面,我们调查了2019年女性BC的发病率、死亡率和伤残调整生命年(DALYs)负担,并评估了30年间BC发病率和死亡率在流行病学、社会经济和健康相关方面的差异。在不同年龄组中,评估了1990年至2019年间归因于不同风险因素的BC死亡率和DALYs的变化。
2019年,BC的发病率、死亡率和DALYs估计分别为382,321例(95%不确定区间:303,308 - 477,173例)[年龄标准化率(ASR)为每10万人35.69例;28.32 - 44.54例]、98,162例(79,216 - 120,112例)死亡(ASR为9.12;7.36 - 11.13)以及3,024,987例(2,477,984 - 3,659,370例)DALYs,2019年的ASR为282.15(230.81 - 341.19)。还观察到,在东亚四个最具代表性的地区中,有两个(中国和日本)在1990年至2019年间年龄标准化发病率上升了60%以上。而在1990年至2019年间,只有日本女性的死亡ASR显著上升了15.3%(95%不确定区间:2.3 - 28),DALYs的ASR上升了12.6%(95%不确定区间:0.5 - 26.9)。总体而言,2019年东亚地区BC发病率和死亡归因于社会人口学指数(SDI)变化的差异分别为88%和81%。1990年至2019年间,死亡和DALYs的最高正百分比变化归因于东亚地区的高体重指数(BMI)、高空腹血糖(FPG)和饮酒。
女性BC的死亡和残疾负担是多种风险因素的结果,主要是由于行为和代谢风险因素。发病率的增加与近年来西方化的生活方式和饮食习惯以及筛查和诊断技术的改进有关,而DALYs的增加主要归因于高BMI、高FPG、饮酒和高红肉饮食。